THE EFFECTIVENESS OF NEURAL THERAPY IN FIBROMYALGIA SYNDROME

Fibromyalgia syndrome (FMS) is characterized by chronic widespread body pain, fatigue, morning stiffness, subjective swelling, sleep disturbances, bowel problems, multiple somatic and cognitive problems. Basically, the impairment of lymphatic circulation caused by the chronic loading of the vegetative nervous system (VSS) is the forerunner. In this context, interference areas are also a significant burden. Regulation of VSS that surrounds the lymphatic system and fight against latent acidosis should be the main treatment approach. In this study, the files of 113 patients who were diagnosed with FMS according to the ACR 1990 Diagnostic Criteria were retrospectively reviewed. In the vast majority of patients, latent acidosis, hormonal dysfunction and multiple destructive areas were detected. A mean of 6.1 ± 3.2 neural therapy sessions was performed. When the good and good categories were assessed together according to the Likert scale, it was observed that 76.1% of the patients were highly effective in neural therapy. It was observed that this ratio continued to be 65.5% after 17.7 ± 15.4 months of treatment. 15.9% of the patients were moderate, 1.8% were mild and 6.2% had no effect. The results has shown that neural therapy can be an effective treatment modality for removing treatment-resistant causes